This article addresses common errors that lead to litigation involving ob/gyn ultrasound, with options to reduce ultrasound-related litigation.
Early imaging is key to detecting anomalies, some of which are unique to multiple gestations and some that also occur with singletons. Any anomaly that occurs in singletons can occur in 1 fetus in a multifetal pregnancy.
Contemporary OB/GYN congratulates Founding Editor John T. Queenan, MD, on the lifetime achievement award presented to him at the 9th Philadelphia Prenatal Conference. Held June 8 to 10 in the city for which it was named, the event was jointly sponsored by the American College of Obstetricians and Gynecologists and the Philadelphia Prenatal Diagnosis Institute/The Philadelphia pregnancy, Genetics and Ultrasound Center.
A collection of ultrasounds showing fetal anomalies in the brain/skull, face, neck, chest, and heart.
A collection of ultrasounds showing fetal anomalies during the first trimester of pregnancy.
Like much of medicine, ultrasound diagnosis of fetal anomalies is both a science and an art. Part 1 of this article will detail, within the text and with images, the anomalies that should not be missed when performing ultrasound during the first and second trimesters of pregnancy.
Second trimester ultrasounds of fetal anomalies in the abdomen, spine, genitourinary, and extremities
A collection of ultrasounds for fetal anomalies in abdominal structures, genitourinary structures, spine, and extremities.
A California woman was 35-years-old when she delivered an infant with severe Down's syndrome and then sued all those involved with the prenatal care and alleged that both physicians were told the parents wanted all available testing because of a family history of birth defects. What's the verdict? Plus more cases.
Retrospective analysis of data on women undergoing surgery for urinary tract endometriosis sheds new light on the role that the surgical team’s expertise has on patient outcome.
Pelvic organ prolapse is a very prevalent condition, affecting up to half of all women over 50 years old. Biological grafts may be useful in certain patients but long-term trials are needed to guide their proper use.